When Nicholas Barlas was in primary school, he asked his dad, George, to speak to his class about what plasma was and how CSL used it to manufacture its products.
Despite his understanding of his dad’s job at the time being limited to “scientist”, he was fascinated by his work and how this company turned what looked like liquid gold into therapies for people whose immune systems were not functioning properly.
Yolanda RedrupRich List editorYolanda Redrup is the editor of the AFR Rich List. She previously reported on technology, healthcare and Street Talk. Connect with Yolanda on Twitter. Email Yolanda at yolanda.redrup@afr.com
Hans van LeeuwenJournalistHans van Leeuwen is The Australian Financial Review’s former Europe correspondent. He is now International Economy editor for The Telegraph UK.
